Long intergenic non-protein coding RNA 2266 (LINC02266)

Long intergenic non-protein coding RNA 2266 (LINC02266) is a long non-coding RNA gene located on human chromosome 4 and classified as an intergenic lncRNA, meaning it does not encode a protein but functions as a regulatory RNA transcript[1][5][7]. There is no current literature indicating that LINC02266 has a directly established role as a therapeutic target, disease biomarker, or a molecule with disease-linked functional characterization; it is an RNA molecule included in genomic databases as an annotated lncRNA without protein-coding potential[1][5][7]. Notes and rationale: - LINC02266 is confirmed as an lncRNA gene, but there is no evidence in the provided results or major databases indicating it acts as a therapeutic "target" (such as receptor, enzyme, transporter, etc.) or that it has a well-described biological or pathological role[1][5][7]. - No information was found regarding drug interactions, mechanism of action, or biomarker status related to LINC02266. - The gene is not misspelled nor does it represent a known, incorrect, or ambiguous entry; its characterization is simply limited[1][5][7]. - The minimal function known pertains to its classification as a long non-coding RNA, consistent with other lincRNAs that can potentially be involved in gene expression regulation[9]—but there's no evidence LINC02266 specifically is therapeutically actionable or directly disease-related in current literature.

Other names

LINC02266